Carlos Azambuja | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Carlos Azambuja

Genia - Genetics Molecular Laboratory, Uruguay


Dr. Azambuja is a Veterinary Medicine and Technology Doctor, graduated from the University of the Republic, Uruguay, and completed postgraduate studies on Modern Biotechnology at the Universidade Federal do Rio Grande do Sul, Brazil. He has participated in several courses on topics such as basic and applied cytogenetics, DNA in vitro amplification and DNA sequencing, among others.

He is the CEO of GENIA – a molecular genetics laboratory devoted to molecular biology.


He has participated in many research projects with well-known institutions, such as the Biological Research Institute Clemente Estable and the Curie Institute in Paris, or the Argentine National Institute for Agricultural Research (INIA), the Honorary Committee Against Cancer and CONICYT, among others.


Dr. Azambuja has published extensively, both at a national and international level, and is a member of several international scientific societies.

Research Interest

molecular genetics,molecular biology,DNA sequencing,Veterinary Medicine


Global Speakers in the subject

Global Experts in the subject